Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antiviral Long Acting Drugs Landing in People Living With HIV (ALADDIN): Prospective, Double-arm, Randomized, Open-label, Implementation-effectiveness Hybrid Type III Study

NCT06468995 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06468995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06468995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antiviral Long Acting Drugs Landing in People Living With HIV (ALADDIN): Prospective, Double-arm, Randomized, Open-label, Implementation-effectiveness Hybrid Type III Study
Lead sponsor
IRCCS San Raffaele
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 2, 2024
Completion date
July 1, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiviral agents, hiv